Jack Figg
YOU?
Author Swipe
View article: OS05.5.A RADIAL GLIAL CELLS AS SOURCE ANTIGEN FOR ADOPTIVE CELLULAR THERAPY IN GLIOBLASTOMA
OS05.5.A RADIAL GLIAL CELLS AS SOURCE ANTIGEN FOR ADOPTIVE CELLULAR THERAPY IN GLIOBLASTOMA Open
BACKGROUND Glioblastoma (GBM) is a highly lethal brain cancer with limited treatment options and poor long-term survival. Adoptive cellular therapy (ACT) has shown promise in targeting GBM, but many ACT strategies rely on patient tumor tis…
View article: 243 Understanding and overcoming the mechanism of resistance to anti-PD-1 monotherapy in brain metastasis
243 Understanding and overcoming the mechanism of resistance to anti-PD-1 monotherapy in brain metastasis Open
Background The average overall survival for patients with brain tumors is only 8 to 12 months. For example, the 5-year survival rate for adults over 40 years old living with Glioblastoma multiforme, a type of brain tumor, is only 6%. The b…